Tarsus Pharmaceuticals, Inc. · NASDAQ:TARS
Azamian Bobak R. sold 10,000 Tarsus Pharmaceuticals, Inc. shares (Form 4)
Traded Sep 4, 2026 · Filed Sep 9, 2026
On Sep 4, 2026, Azamian Bobak R. (Director, President/CEO and Board Chair) sold 10,000 Tarsus Pharmaceuticals, Inc. shares at an average US$90.56 for US$906K under a trading plan, leaving 827,991 shares. Filed Sep 9, 2026 (Form 4).
- Sold
- 10,000 shares
- Price
- US$90.56 average (US$90.27 to US$91.27)
- Value
- US$906K
- Holding after
- 827,991 shares (held indirectly)
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, President/CEO and Board Chair
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 4, 2026 | Common Stock | Sale | 7,100 | US$90.27 | 830,891 | Indirect |
| Sep 4, 2026 | Common Stock | Sale | 2,900 | US$91.27 | 827,991 | Indirect |
Source
Related
- Tarsus Pharmaceuticals, Inc.
- Azamian Bobak R.
- Tarsus Pharmaceuticals, Inc. shareholders
- Form 4 · Azamian Bobak R. · Sep 3, 2026
- Form 4 · Azamian Bobak R. · Jun 22, 2026
- Form 4 · Pyott David E I · Sep 17, 2026
- Form 4 · Yarno Wendy L · Sep 17, 2026
- Form 4 · Link William J Phd · Sep 17, 2026
- Form 4 · Lin Elizabeth Yeu · Sep 9, 2026
- Form 4 · Neervannan Seshadri · Sep 9, 2026